20 hours ago · french drugmaker valneva said on wednesday it reached a settlement agreement with the british government linked to the termination of the supply agreement for its covid- 19 vaccine. la commission européenne avait indiqué lundi envisager de résilier son contrat de fourniture de 60 millions de doses de vaccin contre la covid. vla, a new covid- 19 vaccine developed by valneva, a french biotechnology company, using traditional methods, has now received conditional marketing authorization in the united kingdom. le contrat entre l' union européenne et valneva. 19 hours ago · french drugmaker valneva said on wednesday it reached a settlement agreement with the british government linked to the termination of the supply agreement for its covid- 19 vaccine candidate vla. paris/ london, june 13 ( reuters) - valneva' s ( vls. search only for autorisation vaccin autorisation vaccin valneva valneva.
following receipt of the european commission ( ec) ’ s notice of intent to terminate the advance purchase agreement ( apa) [ 1], valneva proposed a remediation plan, which is now subject to further discussion within. jacques rozier. paris ( agefi- dow jones) - - la société de biotechnologies valneva a confirmé jeudi sa prévision de chiffre d' affaires pour et annoncé qu' elle pourrait obtenir une autorisation de mise sur le. saint- herblain ( france), j – valneva se, a specialty vaccine company, today provides an update on its european inactivated whole- virus covid- 19 vaccine candidate vla. pa) shares dived about 20% on monday after the french drugmaker warned that the future of its covid- 19 vaccine was in jeopardy.